<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34874625</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-846X</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Developmental neurobiology</Title><ISOAbbreviation>Dev Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Microglial TREM2 in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>137</EndPage><MedlinePgn>125-137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/dneu.22864</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is an aggressive motor neuron degenerative disease characterized by selective loss of both upper and lower motor neurons. The mechanisms underlying disease initiation and progression are poorly understood. The involvement of nonmotor neuraxis emphasizes the contribution of glial cells in disease progress. Microglia comprise a unique subset of glial cells and are the principal immune cells in the central nervous system (CNS). Triggering receptor expressed on myeloid cell 2 (TREM2) is a surface receptor that, within the CNS, is exclusively expressed on microglia and plays crucial roles in microglial proliferation, migration, activation, metabolism, and phagocytosis. Genetic evidence has linked TREM2 to neurodegenerative diseases including ALS, but its function in ALS pathogenesis is largely unknown. In this review, we summarize how microglial activation, with a specific focus on TREM2 function, affects ALS progression clinically and experimentally. Understanding microglial TREM2 function will help pinpoint the molecular target for ALS treatment.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Manling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Shunyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosco</LastName><ForeName>Dale B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Aivi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Long-Jun</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0001-8019-3380</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AG069701</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG064159</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088627</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dev Neurobiol</MedlineTA><NlmUniqueID>101300215</NlmUniqueID><ISSNLinking>1932-8451</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498715">TREM2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="Y">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="Y">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="Y">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">TREM2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">disease-associated microglia</Keyword><Keyword MajorTopicYN="N">microglia</Keyword></KeywordList><CoiStatement>Competing interests. The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34874625</ArticleId><ArticleId IdType="mid">NIHMS1768807</ArticleId><ArticleId IdType="pmc">PMC8898078</ArticleId><ArticleId IdType="doi">10.1002/dneu.22864</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, &#x2026; Blurton-Jones M (2017). iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. Neuron, 94(2), 278&#x2013;293 e279. doi:10.1016/j.neuron.2017.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.042</ArticleId><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, Zheng H, &#x2026; Bu G (2015). Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem, 290(43), 26043&#x2013;26050. doi:10.1074/jbc.M115.679043</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.679043</ArticleId><ArticleId IdType="pmc">PMC4646257</ArticleId><ArticleId IdType="pubmed">26374899</ArticleId></ArticleIdList></Reference><Reference><Citation>Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, &#x2026; Schaefer A (2020). Negative feedback control of neuronal activity by microglia. Nature, 586(7829), 417&#x2013;423. doi:10.1038/s41586-020-2777-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2777-8</ArticleId><ArticleId IdType="pmc">PMC7577179</ArticleId><ArticleId IdType="pubmed">32999463</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, &#x2026; Cleveland DW (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312(5778), 1389&#x2013;1392. doi:10.1126/science.1123511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchon A, Dietrich J, &amp; Colonna M (2000). Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol, 164(10), 4991&#x2013;4995. doi:10.4049/jimmunol.164.10.4991</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.10.4991</ArticleId><ArticleId IdType="pubmed">10799849</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, &#x2026; Trojanowski JQ (2012). Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol, 123(3), 395&#x2013;407. doi:10.1007/s00401-011-0932-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0932-x</ArticleId><ArticleId IdType="pmc">PMC3595560</ArticleId><ArticleId IdType="pubmed">22210083</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GC, &amp; Neher JJ (2014). Microglial phagocytosis of live neurons. Nat Rev Neurosci, 15(4), 209&#x2013;216. doi:10.1038/nrn3710</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3710</ArticleId><ArticleId IdType="pubmed">24646669</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, &#x2026; Harms MB (2014). TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol, 71(4), 449&#x2013;453. doi:10.1001/jamaneurol.2013.6237</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6237</ArticleId><ArticleId IdType="pmc">PMC4087113</ArticleId><ArticleId IdType="pubmed">24535663</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, &#x2026; Piccio L (2015). TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol, 129(3), 429&#x2013;447. doi:10.1007/s00401-015-1388-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1388-1</ArticleId><ArticleId IdType="pmc">PMC4667728</ArticleId><ArticleId IdType="pubmed">25631124</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Chen Y, Wei Q, Guo X, Cao B, Ou R, &#x2026; Shang HF (2015). Assessment of TREM2 rs75932628 association with amyotrophic lateral sclerosis in a Chinese population. J Neurol Sci, 355(1&#x2013;2), 193&#x2013;195. doi:10.1016/j.jns.2015.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.05.010</ArticleId><ArticleId IdType="pubmed">26026943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, &#x2026; Carroll MC (2008). T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A, 105(46), 17913&#x2013;17918. doi:10.1073/pnas.0804610105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804610105</ArticleId><ArticleId IdType="pmc">PMC2581614</ArticleId><ArticleId IdType="pubmed">18997009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, &#x2026; Piccio L (2020). TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol, 140(4), 513&#x2013;534. doi:10.1007/s00401-020-02193-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02193-z</ArticleId><ArticleId IdType="pmc">PMC7498497</ArticleId><ArticleId IdType="pubmed">32772264</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, &amp; Patani R (2020). The microglial component of amyotrophic lateral sclerosis. Brain, 143(12), 3526&#x2013;3539. doi:10.1093/brain/awaa309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocozza G, di Castro MA, Carbonari L, Grimaldi A, Antonangeli F, Garofalo S, &#x2026; Limatola C (2018). Ca(2+)-activated K(+) channels modulate microglia affecting motor neuron survival in hSOD1(G93A) mice. Brain Behav Immun, 73, 584&#x2013;595. doi:10.1016/j.bbi.2018.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.07.002</ArticleId><ArticleId IdType="pmc">PMC6129409</ArticleId><ArticleId IdType="pubmed">29981425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Green C, Altschuler G, Wei W, Bury JJ, Heath PR, &#x2026; Hide W (2017). A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathol Commun, 5(1), 23. doi:10.1186/s40478-017-0424-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0424-x</ArticleId><ArticleId IdType="pmc">PMC5353945</ArticleId><ArticleId IdType="pubmed">28302159</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, &#x2026; Ribeiro MJ (2012). Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One, 7(12), e52941. doi:10.1371/journal.pone.0052941</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cserep C, Posfai B, Lenart N, Fekete R, Laszlo ZI, Lele Z, &#x2026; Denes A (2019). Microglia monitor and protect neuronal function via specialized somatic purinergic junctions. Science. doi:10.1126/science.aax6752</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax6752</ArticleId><ArticleId IdType="pubmed">31831638</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia AM, Gallo A, Manzari C, Raho S, Horner DS, Chiara M, &#x2026; Picardi E (2017). Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci Rep, 7(1), 10046. doi:10.1038/s41598-017-10488-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Damisah EC, Rai A, &amp; Grutzendler J (2020). TREM2: Modulator of Lipid Metabolism in Microglia. Neuron, 105(5), 759&#x2013;761. doi:10.1016/j.neuron.2020.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.02.008</ArticleId><ArticleId IdType="pubmed">32135085</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, &#x2026; Gan WB (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci, 8(6), 752&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">15895084</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, &amp; Amit I (2018). Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell, 173(5), 1073&#x2013;1081. doi:10.1016/j.cell.2018.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.05.003</ArticleId><ArticleId IdType="pubmed">29775591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibaj P, Nadrigny F, Steffens H, Scheller A, Hirrlinger J, Schomburg ED, &#x2026; Kirchhoff F (2010). NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia, 58(9), 1133&#x2013;1144. doi:10.1002/glia.20993</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20993</ArticleId><ArticleId IdType="pubmed">20468054</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Montal V, Sirisi S, Lopez-Pernas G, Cervera-Carles L, Querol-Vilaseca M, &#x2026; Clarimon J (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm, 7(5). doi:10.1212/NXI.0000000000000829</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, Mo M, Yi MH, Murugan M, Liu J, Yarlagadda R, &#x2026; Wu LJ (2018). P2Y12R-Dependent Translocation Mechanisms Gate the Changing Microglial Landscape. Cell Rep, 23(4), 959&#x2013;966. doi:10.1016/j.celrep.2018.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.04.001</ArticleId><ArticleId IdType="pmc">PMC5965271</ArticleId><ArticleId IdType="pubmed">29694903</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, Peng J, Swiatkowski P, Mukherjee A, Bispo A, &amp; Wu LJ (2014). Neuronal Hyperactivity Recruits Microglial Processes via Neuronal NMDA Receptors and Microglial P2Y12 Receptors after Status Epilepticus. J Neurosci, 34(32), 10528&#x2013;10540. doi:10.1523/JNEUROSCI.0416-14.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0416-14.2014</ArticleId><ArticleId IdType="pmc">PMC4200107</ArticleId><ArticleId IdType="pubmed">25100587</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, &amp; Wu LJ (2019). Microglia: Lifelong patrolling immune cells of the brain. Prog Neurobiol, 179, 101614. doi:10.1016/j.pneurobio.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6599472</ArticleId><ArticleId IdType="pubmed">31075285</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, &#x2026; Matteoli M (2018). The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. Immunity, 48(5), 979&#x2013;991 e978. doi:10.1016/j.immuni.2018.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.04.016</ArticleId><ArticleId IdType="pubmed">29752066</ArticleId></ArticleIdList></Reference><Reference><Citation>Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J, &#x2026; Ryten M (2013). Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging, 34(12), 2699&#x2013;2714. doi:10.1016/j.neurobiolaging.2013.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.05.001</ArticleId><ArticleId IdType="pmc">PMC3988951</ArticleId><ArticleId IdType="pubmed">23855984</ArticleId></ArticleIdList></Reference><Reference><Citation>Funikov SY, Rezvykh AP, Mazin PV, Morozov AV, Maltsev AV, Chicheva MM, &#x2026; Ustyugov AA (2018). FUS(1&#x2013;359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics, 19(3), 189&#x2013;204. doi:10.1007/s10048-018-0553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-018-0553-9</ArticleId><ArticleId IdType="pubmed">29982879</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, &amp; D&#x2019;Ambrosi N (2017). The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front Aging Neurosci, 9, 242. doi:10.3389/fnagi.2017.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber YN, Sabourin JC, Rabano M, Vivanco M, &amp; Perrin FE (2012). Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS One, 7(4), e36000. doi:10.1371/journal.pone.0036000</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036000</ArticleId><ArticleId IdType="pmc">PMC3338492</ArticleId><ArticleId IdType="pubmed">22558300</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, &#x2026; Huentelman MJ (2013). Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer&#x2019;s disease. Neurobiol Aging, 34(8), 2077 e2011&#x2013;2078. doi:10.1016/j.neurobiolaging.2013.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.02.016</ArticleId><ArticleId IdType="pmc">PMC3830921</ArticleId><ArticleId IdType="pubmed">23582655</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG (2000). Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot. Muscle Nerve, 23(3), 336&#x2013;343. doi:10.1002/(sici)1097-4598(200003)23:3&lt;336::aid-mus4&gt;3.0.co;2-l</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-4598(200003)23:3&lt;336::aid-mus4&gt;3.0.co;2-l</ArticleId><ArticleId IdType="pubmed">10679709</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, &amp; Samulski RJ (2011). Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther, 19(6), 1058&#x2013;1069. doi:10.1038/mt.2011.72</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2011.72</ArticleId><ArticleId IdType="pmc">PMC3129805</ArticleId><ArticleId IdType="pubmed">21487395</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, &#x2026; Alzheimer Genetic Analysis, G. (2013). TREM2 variants in Alzheimer&#x2019;s disease. N Engl J Med, 368(2), 117&#x2013;127. doi:10.1056/NEJMoa1211851</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211851</ArticleId><ArticleId IdType="pmc">PMC3631573</ArticleId><ArticleId IdType="pubmed">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro RJ, Lohmann E, Bras JM, Gibbs JR, Rohrer JD, Gurunlian N, &#x2026; Hardy J (2013). Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol, 70(1), 78&#x2013;84. doi:10.1001/jamaneurol.2013.579</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.579</ArticleId><ArticleId IdType="pmc">PMC4001789</ArticleId><ArticleId IdType="pubmed">23318515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, &#x2026; van den Berg LH (2017). Amyotrophic lateral sclerosis. Nat Rev Dis Primers, 3, 17071. doi:10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, &#x2026; Appel SH (2004). Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol, 55(2), 221&#x2013;235. doi:10.1002/ana.10805</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, &amp; Seaman WE (2009). A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem, 109(4), 1144&#x2013;1156. doi:10.1111/j.1471-4159.2009.06042.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06042.x</ArticleId><ArticleId IdType="pmc">PMC3087597</ArticleId><ArticleId IdType="pubmed">19302484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, &#x2026; Holstege JC (2000). Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis, 7(6 Pt B), 623&#x2013;643. doi:10.1006/nbdi.2000.0299</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Stanford MJ, Pytel P, Roos RP, Weintraub S, &#x2026; Ozdinler PH (2017). Evidence for an early innate immune response in the motor cortex of ALS. J Neuroinflammation, 14(1), 129. doi:10.1186/s12974-017-0896-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-0896-4</ArticleId><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Tan L, Zhu XC, Zhou JS, Cao L, Tan MS, &#x2026; Yu JT (2015). Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice. Neurobiol Aging, 36(12), 3176&#x2013;3186. doi:10.1016/j.neurobiolaging.2015.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.019</ArticleId><ArticleId IdType="pubmed">26364736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Yu JT, Zhu XC, Tan MS, Gu LZ, Zhang YD, &amp; Tan L (2014). Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice. Neurobiol Aging, 35(6), 1243&#x2013;1251. doi:10.1016/j.neurobiolaging.2013.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.026</ArticleId><ArticleId IdType="pubmed">24368090</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, &amp; Charpentier E (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816&#x2013;821. doi:10.1126/science.1225829</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1225829</ArticleId><ArticleId IdType="pmc">PMC6286148</ArticleId><ArticleId IdType="pubmed">22745249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, &#x2026; Stefansson K (2013). Variant of TREM2 associated with the risk of Alzheimer&#x2019;s disease. N Engl J Med, 368(2), 107&#x2013;116. doi:10.1056/NEJMoa1211103</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211103</ArticleId><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, Shibuya K, Sato Y, Misawa S, Nasu S, Sekiguchi Y, &#x2026; Kuwabara S (2012). Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 83(7), 734&#x2013;738. doi:10.1136/jnnp-2011-301782</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301782</ArticleId><ArticleId IdType="pubmed">22566594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, &#x2026; Bergles DE (2013). Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci, 16(5), 571&#x2013;579. doi:10.1038/nn.3357</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, &#x2026; Amit I (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell, 169(7), 1276&#x2013;1290 e1217. doi:10.1016/j.cell.2017.05.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, &#x2026; Haass C (2017). The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J, 36(13), 1837&#x2013;1853. doi:10.15252/embj.201796516</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201796516</ArticleId><ArticleId IdType="pmc">PMC5494459</ArticleId><ArticleId IdType="pubmed">28559417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinberger G, Yamanishi Y, Suarez-Calvet M, Czirr E, Lohmann E, Cuyvers E, &#x2026; Haass C (2014). TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med, 6(243), 243ra286. doi:10.1126/scitranslmed.3009093</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009093</ArticleId><ArticleId IdType="pubmed">24990881</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunemann HH, Ridha BH, Magy L, Wherrett JR, Hemelsoet DM, Keen RW, &#x2026; Paloneva J (2005). The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology, 64(9), 1502&#x2013;1507. doi:10.1212/01.WNL.0000160304.00003.CA</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000160304.00003.CA</ArticleId><ArticleId IdType="pubmed">15883308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kober DL, Alexander-Brett JM, Karch CM, Cruchaga C, Colonna M, Holtzman MJ, &amp; Brett TJ (2016). Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife, 5. doi:10.7554/eLife.20391</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.20391</ArticleId><ArticleId IdType="pmc">PMC5173322</ArticleId><ArticleId IdType="pubmed">27995897</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi H, &amp; Kiyama H (2018). Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Front Cell Neurosci, 12, 206. doi:10.3389/fncel.2018.00206</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00206</ArticleId><ArticleId IdType="pmc">PMC6087757</ArticleId><ArticleId IdType="pubmed">30127720</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, &#x2026; Butovsky O (2017). The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity, 47(3), 566&#x2013;581 e569. doi:10.1016/j.immuni.2017.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriz J, Nguyen MD, &amp; Julien JP (2002). Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis, 10(3), 268&#x2013;278. doi:10.1006/nbdi.2002.0487</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0487</ArticleId><ArticleId IdType="pubmed">12270689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Lorenzini I, Mota TA, Bell S, Mahan TE, Ulrich JD, &#x2026; Baloh RH (2021). C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron, 109(14), 2275&#x2013;2291 e2278. doi:10.1016/j.neuron.2021.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8298293</ArticleId><ArticleId IdType="pubmed">34133945</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, De Septenville A, Guerreiro R, Bras J, Camuzat A, Caroppo P, &#x2026; Brice A (2014). Homozygous TREM2 mutation in a family with atypical frontotemporal dementia. Neurobiol Aging, 35(10), 2419 e2423&#x2013;2419 e2425. doi:10.1016/j.neurobiolaging.2014.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.010</ArticleId><ArticleId IdType="pmc">PMC4208293</ArticleId><ArticleId IdType="pubmed">24910390</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Cheng Z, Zhou L, Darmanis S, Neff NF, Okamoto J, &#x2026; Barres BA (2019). Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron, 101(2), 207&#x2013;223 e210. doi:10.1016/j.neuron.2018.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.12.006</ArticleId><ArticleId IdType="pmc">PMC6336504</ArticleId><ArticleId IdType="pubmed">30606613</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Hong K, Chen H, Niu Y, Duan W, Liu Y, &#x2026; Li C (2019). Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis. Biol Chem, 400(5), 651&#x2013;661. doi:10.1515/hsz-2018-0204</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2018-0204</ArticleId><ArticleId IdType="pubmed">30352020</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Taso O, Wang R, Bayram S, Graham AC, Garcia-Reitboeck P, &#x2026; Salih DA (2020). Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum Mol Genet, 29(19), 3224&#x2013;3248. doi:10.1093/hmg/ddaa209</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa209</ArticleId><ArticleId IdType="pmc">PMC7689298</ArticleId><ArticleId IdType="pubmed">32959884</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YU, Ying Y, Li Y, Eyo UB, Chen T, Zheng J, &#x2026; Wu LJ (2019). Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nat Neurosci, 22(11), 1771&#x2013;1781. doi:10.1038/s41593-019-0511-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0511-3</ArticleId><ArticleId IdType="pmc">PMC6858573</ArticleId><ArticleId IdType="pubmed">31636449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma MW, Wang J, Zhang Q, Wang R, Dhandapani KM, Vadlamudi RK, &amp; Brann DW (2017). NADPH oxidase in brain injury and neurodegenerative disorders. Mol Neurodegener, 12(1), 7. doi:10.1186/s13024-017-0150-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0150-7</ArticleId><ArticleId IdType="pmc">PMC5240251</ArticleId><ArticleId IdType="pubmed">28095923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, &#x2026; Trojanowski JQ (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol, 61(5), 427&#x2013;434. doi:10.1002/ana.21147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, &#x2026; Phatnani H (2019). Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science, 364(6435), 89&#x2013;93. doi:10.1126/science.aav9776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, &#x2026; Lopez-Vales R (2016). CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci Rep, 6, 25663. doi:10.1038/srep25663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25663</ArticleId><ArticleId IdType="pmc">PMC4865981</ArticleId><ArticleId IdType="pubmed">27174644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazaheri F, Snaidero N, Kleinberger G, Madore C, Daria A, Werner G, &#x2026; Haass C (2017). TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep, 18(7), 1186&#x2013;1198. doi:10.15252/embr.201743922</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201743922</ArticleId><ArticleId IdType="pmc">PMC5494532</ArticleId><ArticleId IdType="pubmed">28483841</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F, Molawi K, &amp; Zychlinsky A (2010). Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A, 107(29), 13046&#x2013;13050. doi:10.1073/pnas.1002396107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, &#x2026; Meininger V (2010). SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet, 47(8), 554&#x2013;560. doi:10.1136/jmg.2010.077180</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2010.077180</ArticleId><ArticleId IdType="pubmed">20577002</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, &#x2026; Shaw CE (2013). Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol, 125(2), 273&#x2013;288. doi:10.1007/s00401-012-1043-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, Spampinato AG, &amp; Cavallaro S (2017). Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets. Mediators Inflamm, 2017, 7070469. doi:10.1155/2017/7070469</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7070469</ArticleId><ArticleId IdType="pmc">PMC5610842</ArticleId><ArticleId IdType="pubmed">29081603</ArticleId></ArticleIdList></Reference><Reference><Citation>Muffat J, Li Y, Yuan B, Mitalipova M, Omer A, Corcoran S, &#x2026; Jaenisch R (2016). Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat Med, 22(11), 1358&#x2013;1367. doi:10.1038/nm.4189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4189</ArticleId><ArticleId IdType="pmc">PMC5101156</ArticleId><ArticleId IdType="pubmed">27668937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder DW, Kurland LT, Offord KP, &amp; Beard CM (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36(4), 511&#x2013;517. doi:10.1212/wnl.36.4.511</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.36.4.511</ArticleId><ArticleId IdType="pubmed">3960325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A, Kirchhoff F, &amp; Helmchen F (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 308(5726), 1314&#x2013;1318. doi:10.1126/science.1110647</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1110647</ArticleId><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, &#x2026; Di Paolo G (2020). TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron, 105(5), 837&#x2013;854 e839. doi:10.1016/j.neuron.2019.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.12.007</ArticleId><ArticleId IdType="pubmed">31902528</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, Muhammad AK, &#x2026; Baloh RH (2016). C9orf72 is required for proper macrophage and microglial function in mice. Science, 351(6279), 1324&#x2013;1329. doi:10.1126/science.aaf1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T, Yamasaki R, Takeuchi H, Kadomatsu K, Kira JI, &amp; Jinno S (2017). Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Eur J Neurosci, 46(4), 2001&#x2013;2014. doi:10.1111/ejn.13650</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13650</ArticleId><ArticleId IdType="pubmed">28715117</ArticleId></ArticleIdList></Reference><Reference><Citation>Olesen MN, Wuolikainen A, Nilsson AC, Wirenfeldt M, Forsberg K, Madsen JS, &#x2026; Asgari N (2020). Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm, 7(3). doi:10.1212/NXI.0000000000000697</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000697</ArticleId><ArticleId IdType="pmc">PMC7136052</ArticleId><ArticleId IdType="pubmed">32123048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SH, Wu F, Harrich D, Garcia-Martinez LF, &amp; Gaynor RB (1995). Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol, 69(6), 3584&#x2013;3596. doi:10.1128/JVI.69.6.3584-3596.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, &#x2026; Peltonen L (2002). Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet, 71(3), 656&#x2013;662. doi:10.1086/342259</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342259</ArticleId><ArticleId IdType="pmc">PMC379202</ArticleId><ArticleId IdType="pubmed">12080485</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, &#x2026; Haass C (2019). Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci, 22(2), 191&#x2013;204. doi:10.1038/s41593-018-0296-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0296-9</ArticleId><ArticleId IdType="pmc">PMC6417433</ArticleId><ArticleId IdType="pubmed">30617257</ArticleId></ArticleIdList></Reference><Reference><Citation>Peplonska B, Berdynski M, Mandecka M, Barczak A, Kuzma-Kozakiewicz M, Barcikowska M, &amp; Zekanowski C (2018). TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients. Amyotroph Lateral Scler Frontotemporal Degener, 19(5&#x2013;6), 407&#x2013;412. doi:10.1080/21678421.2018.1451894</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1451894</ArticleId><ArticleId IdType="pubmed">29557178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP, Longone P, &#x2026; Zona C (2003). Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett, 351(3), 153&#x2013;156. doi:10.1016/j.neulet.2003.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2003.07.010</ArticleId><ArticleId IdType="pubmed">14623129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, &amp; Zhang F (2013). Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 8(11), 2281&#x2013;2308. doi:10.1038/nprot.2013.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.143</ArticleId><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, &#x2026; Ross OA (2013). TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson&#x2019;s disease. Mol Neurodegener, 8, 19. doi:10.1186/1750-1326-8-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-19</ArticleId><ArticleId IdType="pmc">PMC3691612</ArticleId><ArticleId IdType="pubmed">23800361</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, &amp; Traynor BJ (2014). State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci, 17(1), 17&#x2013;23. doi:10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C, &amp; Wood MJA (2018). Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol, 14(1), 9&#x2013;21. doi:10.1038/nrneurol.2017.148</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.148</ArticleId><ArticleId IdType="pubmed">29192260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, &#x2026; et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362(6415), 59&#x2013;62. doi:10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol, 65 Suppl 1, S3&#x2013;9. doi:10.1002/ana.21543</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21543</ArticleId><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, Malm T, &#x2026; Landreth GE (2015). Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer&#x2019;s disease. J Neurosci, 35(16), 6532&#x2013;6543. doi:10.1523/JNEUROSCI.4586-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4586-14.2015</ArticleId><ArticleId IdType="pmc">PMC4405560</ArticleId><ArticleId IdType="pubmed">25904803</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H, &amp; Haass C (2017). An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med, 9(10), 1356&#x2013;1365. doi:10.15252/emmm.201707672</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201707672</ArticleId><ArticleId IdType="pmc">PMC5623859</ArticleId><ArticleId IdType="pubmed">28855300</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, &#x2026; Miller TM (2021). Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc Natl Acad Sci U S A, 118(27). doi:10.1073/pnas.2100356118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100356118</ArticleId><ArticleId IdType="pmc">PMC8271763</ArticleId><ArticleId IdType="pubmed">34187891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra A, Abiega O, Shahraz A, &amp; Neumann H (2013). Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci, 7, 6. doi:10.3389/fncel.2013.00006</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00006</ArticleId><ArticleId IdType="pmc">PMC3558702</ArticleId><ArticleId IdType="pubmed">23386811</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Aloizou AM, Liampas I, Tsouris Z, Mentis AA, Nasios G, &#x2026; Dardiotis E (2021). Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis. Mol Biol Rep. doi:10.1007/s11033-021-06312-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06312-1</ArticleId><ArticleId IdType="pubmed">33826063</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, &amp; Colonna M (2018). Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med, 215(3), 745&#x2013;760. doi:10.1084/jem.20171529</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20171529</ArticleId><ArticleId IdType="pmc">PMC5839761</ArticleId><ArticleId IdType="pubmed">29321225</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, &#x2026; Lee VM (2018). Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci, 21(3), 329&#x2013;340. doi:10.1038/s41593-018-0083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Rochford CD, &amp; Neumann H (2005). Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med, 201(4), 647&#x2013;657. doi:10.1084/jem.20041611</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041611</ArticleId><ArticleId IdType="pmc">PMC2213053</ArticleId><ArticleId IdType="pubmed">15728241</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, &amp; Lacomis D (2016). The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol, 138, 225&#x2013;238. doi:10.1016/B978-0-12-802973-2.00013-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, &#x2026; Gale Hammell M (2019). Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep, 29(5), 1164&#x2013;1177 e1165. doi:10.1016/j.celrep.2019.09.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr., &amp; Cleveland DW (2016). Decoding ALS: from genes to mechanism. Nature, 539(7628), 197&#x2013;206. doi:10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, &#x2026; Bendotti C (2003). Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci, 23(2), 180&#x2013;192. doi:10.1016/s1044-7431(03)00022-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1044-7431(03)00022-8</ArticleId><ArticleId IdType="pubmed">12812752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, &#x2026; Colonna M (2017). TREM2 Maintains Microglial Metabolic Fitness in Alzheimer&#x2019;s Disease. Cell, 170(4), 649&#x2013;663 e613. doi:10.1016/j.cell.2017.07.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.023</ArticleId><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, Ulland TK, Colonna M, &amp; Holtzman DM (2017). Elucidating the Role of TREM2 in Alzheimer&#x2019;s Disease. Neuron, 94(2), 237&#x2013;248. doi:10.1016/j.neuron.2017.02.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.042</ArticleId><ArticleId IdType="pubmed">28426958</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierre AD, &amp; Wu LJ (2021). How microglia sense and regulate neuronal activity. Glia, 69(7), 1637&#x2013;1653. doi:10.1002/glia.23961</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23961</ArticleId><ArticleId IdType="pmc">PMC8113084</ArticleId><ArticleId IdType="pubmed">33369790</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Weehaeghe D, Van Schoor E, De Vocht J, Koole M, Attili B, Celen S, &#x2026; Van Laere K (2020). TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study. J Nucl Med, 61(4), 604&#x2013;607. doi:10.2967/jnumed.119.231985</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.231985</ArticleId><ArticleId IdType="pmc">PMC7198372</ArticleId><ArticleId IdType="pubmed">31562223</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr., &#x2026; Bellingham MC (2008). Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci, 28(43), 10864&#x2013;10874. doi:10.1523/JNEUROSCI.1340-08.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pmc">PMC3844745</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, &#x2026; Shaw CE (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323(5918), 1208&#x2013;1211. doi:10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Cheah BC, &amp; Kiernan MC (2009). Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Exp Neurol, 220(1), 177&#x2013;182. doi:10.1016/j.expneurol.2009.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.08.017</ArticleId><ArticleId IdType="pubmed">19716820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, &amp; Kiernan MC (2008). Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain, 131(Pt 6), 1540&#x2013;1550. doi:10.1093/brain/awn071</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, &#x2026; Lee VM (2015). Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol, 130(5), 643&#x2013;660. doi:10.1007/s00401-015-1460-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, &#x2026; Colonna M (2020). Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer&#x2019;s disease model. J Exp Med, 217(9). doi:10.1084/jem.20200785</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200785</ArticleId><ArticleId IdType="pmc">PMC7478730</ArticleId><ArticleId IdType="pubmed">32579671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, &#x2026; Colonna M (2015). TREM2 lipid sensing sustains the microglial response in an Alzheimer&#x2019;s disease model. Cell, 160(6), 1061&#x2013;1071. doi:10.1016/j.cell.2015.01.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, &amp; Baloh RH (2009). TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A, 106(44), 18809&#x2013;18814. doi:10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, &#x2026; Kumar-Singh S (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A, 107(8), 3858&#x2013;3863. doi:10.1073/pnas.0912417107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Li Y, Wei Y, Bosco DB, Xie M, Zhao MG, &#x2026; Wu LJ (2020). Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun, 89, 245&#x2013;255. doi:10.1016/j.bbi.2020.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.028</ArticleId><ArticleId IdType="pmc">PMC7572576</ArticleId><ArticleId IdType="pubmed">32621847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, &amp; Walter J (2013). Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage. J Biol Chem, 288(46), 33027&#x2013;33036. doi:10.1074/jbc.M113.517540</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.517540</ArticleId><ArticleId IdType="pmc">PMC3829152</ArticleId><ArticleId IdType="pubmed">24078628</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie M, Liu YU, Zhao S, Zhang L, Bosco DB, Pang Y-P, &#x2026; Wu L-J (2021). TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci, In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741737</ArticleId><ArticleId IdType="pubmed">34916658</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Rao Y, Huang Y, Zhou T, Feng R, Xiong S, &#x2026; Peng B (2020). Efficient Strategies for Microglia Replacement in the Central Nervous System. Cell Rep, 32(6), 108041. doi:10.1016/j.celrep.2020.108041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108041</ArticleId><ArticleId IdType="pubmed">32783928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Qin C, Hu ZW, Zhou LQ, Yu HH, Chen M, &#x2026; Tian DS (2021). Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system. Neurobiol Dis, 152, 105290. doi:10.1016/j.nbd.2021.105290</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105290</ArticleId><ArticleId IdType="pubmed">33556540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Liu X, He Q, Zhou L, Yuan Z, &amp; Zhao S (2016). Vps35-dependent recycling of Trem2 regulates microglial function. Traffic, 17(12), 1286&#x2013;1296. doi:10.1111/tra.12451</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12451</ArticleId><ArticleId IdType="pubmed">27717139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, &#x2026; Grutzendler J (2016). TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron, 92(1), 252&#x2013;264. doi:10.1016/j.neuron.2016.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.016</ArticleId><ArticleId IdType="pubmed">27710785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Liu Y, Liu X, Li S, Cheng C, Chen S, &amp; Le W (2018). Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model. Transl Neurodegener, 7, 35. doi:10.1186/s40035-018-0138-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0138-4</ArticleId><ArticleId IdType="pmc">PMC6309063</ArticleId><ArticleId IdType="pubmed">30607245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, &#x2026; Xu H (2018). TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function. Neuron, 97(5), 1023&#x2013;1031 e1027. doi:10.1016/j.neuron.2018.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.01.031</ArticleId><ArticleId IdType="pmc">PMC5889092</ArticleId><ArticleId IdType="pubmed">29518356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, &#x2026; Bu G (2017). Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med, 214(3), 597&#x2013;607. doi:10.1084/jem.20160844</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160844</ArticleId><ArticleId IdType="pmc">PMC5339672</ArticleId><ArticleId IdType="pubmed">28209725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Chen XF, Zhang ZL, Wang Z, Shi XZ, Xu K, &#x2026; Bu G (2015). DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response. J Biol Chem, 290(25), 15866&#x2013;15877. doi:10.1074/jbc.M115.645986</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.645986</ArticleId><ArticleId IdType="pmc">PMC4505493</ArticleId><ArticleId IdType="pubmed">25957402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, &#x2026; Chen XF (2019). Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer&#x2019;s disease model. Nat Commun, 10(1), 1365. doi:10.1038/s41467-019-09118-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09118-9</ArticleId><ArticleId IdType="pmc">PMC6433910</ArticleId><ArticleId IdType="pubmed">30911003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Mareljic N, Michaelsen M, Parhizkar S, Heindl S, Nuscher B, &#x2026; Edbauer D (2020). Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Mol Med, 12(2), e10919. doi:10.15252/emmm.201910919</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910919</ArticleId><ArticleId IdType="pmc">PMC7005532</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou SL, Tan CC, Hou XH, Cao XP, Tan L, &amp; Yu JT (2019). TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. J Alzheimers Dis, 68(3), 1171&#x2013;1184. doi:10.3233/JAD-181038</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-181038</ArticleId><ArticleId IdType="pubmed">30883352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Ulland TK, &amp; Colonna M (2018). TREM2-Dependent Effects on Microglia in Alzheimer&#x2019;s Disease. Front Aging Neurosci, 10, 202. doi:10.3389/fnagi.2018.00202</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00202</ArticleId><ArticleId IdType="pmc">PMC6046445</ArticleId><ArticleId IdType="pubmed">30038567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, &#x2026; Cleveland DW (2020). Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci, 23(5), 615&#x2013;624. doi:10.1038/s41593-020-0619-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>